Chinese investors lead another monster round into this early cancer detection company
May 21, 2018 at 20:37 PM EDT
The Menlo Park company had already raised $1.2 billion; now it's adding $300 million, mainly from Chinese investors, as it aims to develop a simple blood test to discover cancers early.